NCT06504836 Kinematic Biofeedback on Gait Quality in Stroke
| NCT ID | NCT06504836 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Yang Ming Chiao Tung University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-10-01 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Walking disorder is the most common and concerning issue for individuals with stroke. Previous studies have often used improvements in walking speed and distance as reference indicators for the advancement of gait performance in individuals with stroke. However, for individuals with chronic stroke, considering gait symmetry and variability to enhance gait quality as the primary intervention target may be more crucial. According to a literature review, it can be inferred that the application of biofeedback to detect gait quality may be an effective approach to improve gait symmetry and variability in individuals with stroke. However, there is still insufficient research evidence on this issue. Therefore, this study aims to investigate the effects of a kinematic biofeedback device system, which detects hip joint angles, on gait quality in individuals with chronic stroke.
Eligibility Criteria
Inclusion Criteria: * First stroke * Stroke onset time ≥ 6 months * Functional Ambulation Category ≥3 * Passive range of motion of affected hip extension is at least 10 degrees * Mini-Mental State Measurement score ≥ 24 points Exclusion Criteria: * Modified Ashworth Scale of affected ankle plantar flexors ≥ 2 * Muscle strength of affected ankle plantar flexors via Manual Muscle Testing ≤ 1 * Uncorrected auditory impairment * Severe cardiovascular disease or uncontrolled hypertension * Other orthopedic diseases that may affect walking ability * Other neurological disease except stroke
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06504836 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06504836 currently recruiting?
Yes, NCT06504836 is actively recruiting participants. Contact the research team at yryang@nycu.edu.tw for enrollment information.
Where is the NCT06504836 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06504836 clinical trial?
NCT06504836 is sponsored by National Yang Ming Chiao Tung University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.